STP-133G

N/A

Report date: 2023/12/07 10:01:57
NME

Base Information

Drug NameSTP-133G
Drug Alias NameSTP-133G
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceApolipoprotein C-III inhibitorsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsApolipoprotein C-IIIProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsDyslipidemiasMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSirnaomicsSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsDyslipidemiasMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A